Trastuzumab Biosimilar Litigation update (US): Genentech VS Tanvex Case update
As previously reported (Click here to view previous post), Genentech and Tanvex reached an agreement in January 2022 to end the BPCIA dispu...
Intellectual Property (IP) protection is a crucial yet often overlooked aspect of running a successful startup. A solid IP strategy can help...